🇺🇸 FDA
Patent

US 7875622

Methods and compositions for treating pulmonary hypertension and related diseases and disorders

granted A61KA61K31/198A61K31/405

Quick answer

US patent 7875622 (Methods and compositions for treating pulmonary hypertension and related diseases and disorders) held by LEXICON PHARMACEUTICALS, INC. expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/198, A61K31/405, A61K31/4192, A61K31/4418